DeepMed Research

RUTGERS, THE STATE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

CINJALL: Treatment for Children With Acute Lymphocytic Leukemia

Phase 2

Completed

Conditions: Acute Lymphocytic Leukemia

Interventions: Drug: L-asparaginase
Drug: aminopterin
Drug: daunomycin
Drug: dexamethasone
Drug: cyclophosphamide
Drug: 6-mercaptopurine
Drug: cytarabine
Drug: methotrexate
Drug: vincristine
Drug: Triple Intrathecal Therapy (MTX, Cytarabine, Hydrocortisone)
Drug: Leucovorin
Drug: 6-thioguanine

First Posted Date: 2005-09-15

Last Posted Date: 2014-06-09

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 60

Registration Number: NCT00176462

Locations: 🇺🇸
Jersey Shore University Medical Center, Neptune, New Jersey, United States
🇺🇸
Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2

Terminated

Conditions: Prostate Cancer

Interventions: Dietary Supplement: licorice root extract
Drug: docetaxel

First Posted Date: 2005-09-15

Last Posted Date: 2023-12-22

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 10

Registration Number: NCT00176631

Locations: 🇺🇸
Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

The Use of Capnography as a Guide for Oral Intubation

Terminated

Conditions: Measurement

Interventions: Procedure: Capnography

First Posted Date: 2005-09-15

Last Posted Date: 2017-01-27

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 20

Registration Number: NCT00176683

Locations: 🇺🇸
New Jersey Medical School, Newark, New Jersey, United States

Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate

Phase 1

Terminated

Conditions: Leukemia

Interventions: Drug: choline magnesium trisalicylate
Drug: Dexamethasone

First Posted Date: 2005-09-12

Last Posted Date: 2013-11-19

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 15

Registration Number: NCT00156299

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Effectiveness of Cognitive-Affective Behavior Therapy for the Treatment of Somatization Disorder

Phase 2

Completed

Conditions: Somatization Disorder

Interventions: Behavioral: Cognitive-Affective Behavior Therapy
Behavioral: Augmented Standard Medical Care

First Posted Date: 2005-09-08

Last Posted Date: 2014-02-20

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 88

Registration Number: NCT00149760

Locations: 🇺🇸
Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, New Jersey, United States

Green Tea and Ultraviolet Light-induced Skin Damage

Phase 2

Terminated

Conditions: Healthy

Interventions: Drug: Green Tea
Drug: Placebo

First Posted Date: 2005-08-24

Last Posted Date: 2017-09-06

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 68

Registration Number: NCT00134381

Locations: 🇺🇸
UMDNJ Division of Clinical Pharmacology, New Brunswick, New Jersey, United States

Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia

Phase 2

Terminated

Conditions: Precancerous/Nonmalignant Condition
Prostate Cancer

Interventions: Dietary Supplement: calcitriol
Procedure: observation

First Posted Date: 2005-07-11

Last Posted Date: 2015-05-27

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 12

Registration Number: NCT00118066

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
🇺🇸
Saint Peter's University Hospital, New Brunswick, New Jersey, United States
🇺🇸
Central Jersey Oncology Center, PA - East Brunswick, East Brunswick, New Jersey, United States

and more 2 locations

Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease

Phase 3

Completed

Conditions: Cardiovascular Diseases
Thromboembolism
Pneumonia
Hematologic Diseases
Myocardial Infarction
Heart Diseases
Cerebrovascular Accident
Anemia

Interventions: Biological: Liberal (10 g/dL) Transfusion Strategy
Biological: Restrictive (Symptomatic) Transfusion Strategy

First Posted Date: 2003-10-13

Last Posted Date: 2020-11-16

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 2016

Registration Number: NCT00071032

Locations: 🇺🇸
University Medicine & Dentistry of NJ, New Brunswick, New Jersey, United States

Treatment of Depression in Parkinson's Disease Trial

Phase 2

Completed

Conditions: Parkinson Disease
Depression

Interventions: Other: placebo
Drug: paroxetine
Drug: Nortriptyline

First Posted Date: 2003-06-13

Last Posted Date: 2015-11-24

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 52

Registration Number: NCT00062738

Locations: 🇺🇸
Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Carotid Revascularization Endarterectomy Versus Stenting Trial

Not Applicable

Completed

Conditions: Stroke
Myocardial Infarction
Atherosclerosis
Carotid Stenosis
Cerebral Infarction

Interventions: Procedure: Carotid Endarterectomy (CEA)
Device: Carotid Artery Stenting (CAS)

First Posted Date: 2000-02-28

Last Posted Date: 2017-05-17

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 2502

Registration Number: NCT00004732

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Piedmont Hospital/Fuqua Heart Center, Atlanta, Georgia, United States

and more 112 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy